Related Experiment Video
Updated: Aug 11, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Endometrial angiogenesis: from physiology to pathology
G Krikun1, F Schatz, C J Lockwood
1Yale University School of Medicine, Department of Ob/Gyn, 333 Cedars Street, P.O. Box 208063, New Haven, CT 06520-8063, USA. graciela.krikun@yale.edu
Annals of the New York Academy of Sciences
|February 26, 2005
Summary
This study examines key factors in blood vessel formation, focusing on vascular endothelial growth factor (VEGF) and angiopoietins in the human endometrium. It highlights their roles in both normal and abnormal endometrial conditions.
Area of Science:
- Reproductive biology
- Vascular biology
- Endocrinology
Background:
- Angiogenesis is crucial for numerous physiological processes.
- Vascular endothelial growth factor (VEGF) and angiopoietins are key regulators of angiogenesis.
- Endometrial angiogenesis plays a vital role in reproductive health and disease.
Purpose of the Study:
- To investigate the expression patterns of VEGF and angiopoietins in the human endometrium.
- To emphasize the expression and significance of angiopoietins in endometrial physiology and pathology.
- To provide insights into the molecular mechanisms of endometrial vascularization.
Main Methods:
- Analysis of gene and protein expression of VEGF and angiopoietins.
- Immunohistochemical staining of endometrial tissue.
- Correlation of factor expression with endometrial status (e.g., proliferative, secretory phases, pathological conditions).
Main Results:
- Differential expression of VEGF and angiopoietins observed across the endometrial cycle.
- Specific angiopoietins show altered expression in pathological endometrial states.
- Evidence suggests a coordinated role of VEGF and angiopoietins in regulating endometrial vascular remodeling.
Conclusions:
- VEGF and angiopoietins are critical regulators of human endometrial angiogenesis.
- Understanding angiopoietin expression is essential for comprehending endometrial function and dysfunction.
- Further research into these factors may reveal therapeutic targets for endometrial disorders.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...